Form 4: OSR Holdings CEO Kuk Hyoun Hwang Reports Significant Share Acquisitions Following Business Combination
SEC Form 4 Filing
Kuk Hyoun Hwang, President and CEO of OSR Holdings, reports the acquisition of shares through conversions and a business combination, significantly increasing his indirect beneficial ownership.
Summary
- This Form 4 filing details changes in beneficial ownership for Kuk Hyoun Hwang, President and CEO of OSR Holdings, Inc.
- The report covers transactions occurring on February 14, 2025, related to the business combination between Bellevue Life Sciences Acquisition Corp. and OSR Holdings Co., Ltd.
- Hwang indirectly acquired shares of common stock through Bellevue Global Life Sciences Investors LLC (43,000 shares), BCM Europe AG (7,531,634 shares), and Bellevue Capital Management LLC (3,123,970 shares).
- These acquisitions stem from the conversion of private placement rights and the exchange of shares in OSR Holdings Co., Ltd. during the business combination.
- Following these transactions, Hwang's indirect beneficial ownership totals 2,043,500 shares through Bellevue Global Life Sciences Investors LLC, 9,575,134 shares through BCM Europe AG, and 12,699,104 shares through Bellevue Capital Management LLC.
Sentiment
Score: 7
Explanation: The document primarily reports factual information about share acquisitions. The increased ownership by the CEO is generally viewed positively, suggesting confidence in the company's prospects.
Positives
- The report indicates increased ownership by the CEO, which can be seen as a positive sign of confidence in the company's future.
Industry Context
Form 4 filings are standard practice for reporting changes in beneficial ownership by company insiders, providing transparency to the market.
Stakeholder Impact
- Shareholders may view the increased ownership by the CEO as a positive signal.
- The filing provides transparency to the market regarding insider transactions.
Key Dates
| Date | Description |
|---|---|
| 02/14/2025 | Date of the transactions: acquisition of shares of common stock. |
| 02/19/2025 | Date of signature of the Form 4 filing. |
Keywords
OSR Holdings, Kuk Hyoun Hwang, Beneficial Ownership, Form 4, Share Acquisition, Business Combination, Bellevue Life Sciences, BCM Europe AG, Bellevue Capital Management
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.